Immunology of the Fetus and Newborn

Avery's Diseases of the Newborn

Volumn , Issue , 2005, Pages 447-474

  Williams, Calvin B ^a,b   Cole, F Sessions ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Children's Hospital of Wisconsin   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33644656623     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072169347-7.50037-8     Document Type: Chapter

References (353)

1. Abe N, Katamura K, Shintaku N, et al. Prostaglandin E2 and IL-4 provide naive CD4+ T cells with distinct inhibitory signals for the priming of IFN-gamma production. Cell Immunol 1997, 181:86-92.
2. Abman SH, Groothius JR Pathophysiology and treatment of bronchopulmonary dysplasia: Current issues. Pediatr Clin North Am 1994, 41:277-315.
3. Abo T Miller CA, Gartland GL, et al. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med 1983, 157:273-284.
4. Adinolfi M, Gardner B Synthesis of beta-1E and beta-1C components of complement in human foetuses. Acta Paediatr Scand 1967, 56:450-454.
5. Adkins B T-cell function in newborn mice and humans [see comments]. Immunol Today 1999, 20:330-335.
6. Use of anthrax vaccine in the United States. MMWR Morbid Mortal Wkly Rep 2000, 49(RR-15):1-20. Advisory Committee on Immunization Practices (ACIP).
7. Alegre ML, Thompson CB T-cell regulation by CD28 and CTLA-4. J Immunol 2001, 167:4936-4941.
8. Alford CA, Blankenship WJ, Straumfjord JB The diagnostic significance of IgM globulin elevations in neonate infants with chronic intrauterine infections. Birth Defects 1969, 4:3.
9. Allman D, Li J, Hardy RR Commitment to the B lymphoid lineage occurs before DH-JH recombination. J Exp Med 1999, 189:735-740.
10. Immunization During Pregnancy (Technical bulletin No. 160) 1991, American College of Obstetricians and Gynecologists, ACOG, Washington, DC.
11. Amstey MS, Insel R, Munoz J, et al. Fetal-neonatal passive immunization against Hemophilus influenzae, type b. Am J Obstet Gynecol 1985, 153:607-611.
12. Andersson U, Britton S, De Ley M, et al. Evidence for the ontogenic precedence of suppressor T cell functions in the human neonate. Eur J Immunol 1983, 13:6-13.
13. Atkinson WL, Pickering LK, Schwartz B, et al. Centers for Disease Control and Prevention. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and American Academy of Family Physicians (AAFP). MMWR Morbid Mortal Wkly Rep 2002, 51(RR-2):1-36.
14. Baker CJ, Kasper DL Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976, 294:753-756.
15. Baker CJ, Webb BJ, Kasper DL, et al. The role of complement and antibody in opsonophagocytosis of type II group B streptococci. J Infect Dis 1986, 154:47-54.
16. Baker CJ, Rench MA, Edwards MS, et al. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus [see comments]. N Engl J Med 1988, 319:1180-1185.
17. Baker CJ, Melish ME, Hall RT, et al. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates [see comments]. N Engl J Med 1992, 327:213-219.
18. Baker DA, Hameed C, Tejani N, et al. Lymphocyte subsets in the neonates of preeclamptic mothers. American J Reproductive Immunology & Microbiology 1987, 14:107-109.
19. Baley JE, Schacter BZ Mechanisms of diminished natural killer cell activity in pregnant women and neonates. J Immunol 1985, 134:3042-3048.
20. Ballow M, Cates KL, Rowe JC, et al. Development of the immune system in very low birth weight (less than 1500 g) premature infants: Concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 1986, 20:899-904.
21. Bancalari E Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Pediatrics 2001, 107:1425-1426.
22. Barrington KJ Postnatal steroids and neurodevelopmental outcomes: A problem in the making. Pediatrics 2002, 109:330-338.
23. Barton K, Muthusamy N, Fischer C, et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 1998, 9:555-563.
24. Baskett TF, Parsons ML, Peddle LJ The experience and effectiveness of the Nova Scotia Rh program, 1964-84. CMAJ 1986, 134:1259-1261.
25. Bazaral M, Orgel HA, Hamburger RN IgE levels in normal infants and mothers and an inheritance hypothesis. J Immunol 1971, 107:794-801.
26. Beer AE, Billingham RE Maternally acquired runt disease. Science 1973, 179:240-243.
27. Beer AE, Billingham RE The Immunobiology of Mammalian Reproduction 1976, Prentice-Hall, Englewood Cliffs, NJ.
28. Beer AE, Billingham RE, Yang SL Maternally induced transplantation immunity, tolerance, and runt disease in rats. J Exp Med 1972, 135:808-826.
29. Beer AE, Kwak JY, Ruiz JE The biological basis of passage of fetal cellular material into the maternal circulation. Ann N Y Acad Sci 1994, 731:21-35.
30. Bellanti JA, Kadlec JV, Escobar-Gutierrez A Cytokines and the immune response. Pediatr Clin North Am 1994, 41:597-621.
31. Benoist C, Mathis D T-lymphocyte differentiation and biology. Fundamental Immunology 1999, 367-409. Lippincott-Raven, Philadelphia. 4th ed. W.E. Paul (Ed.).
32. Berlin G, Selbing A, Ryden G Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin. Lancet 1985, 1(8438):1153.
33. Bernbaum J, Daft A, Samuelson J, et al. Half-dose immunization for diphtheria, tetanus, pertussis: Response of preterm infants [see comments]. Pediatrics 1989, 83:471-476.
34. Bevan MJ In thymic selection, peptide diversity gives and takes away. Immunity 1997, 7:175-178.
35. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996, 93:705-708.
36. Biassoni R, Cantoni C, Pende D, et al. Human natural killer cell receptors and coreceptors. Immunol Rev 2001, 181:203-214.
37. Billingham RE Transplantation immunity and the maternal-fetal relation. N Engl J Med 1964, 270:667-672.
38. Billington D Evidence for trophoblast immunogenicity in the induction of maternal alloantibody formation in murine pregnancy: Reproductive immunology: Materno-fetal relationship. Colloque INSERM 1987, 154:17.
39. Blackburn MR, Kellems RE, Smith PT, et al. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J Clin Invest 2001, 108:131-141.
40. Bobe P, Kiger N Immunogenetic studies of spontaneous abortion in mice. III: Non-H-2 antigens and gestation. J Immunogenet 1989, 16:223-231.
41. Bobe P, Chaouat G, Stanislawski M, et al. Immunogenetic studies of spontaneous abortion in mice. II: Antiabortive effects are independent of systemic regulatory mechanisms. Cell Immunol 1986, 98:477-485.
42. Bofill M, Janossy G, Janossa M, et al. Human B cell development. II: Subpopulations in the human fetus. J Immunol 1985, 134:1531-1538.
43. Bromley SK, Burack WR, Johnson KG, et al. The immunological synapse. Annu Rev Immunol 2001, 19:375-396.
44. Brugnoni D, Airo P, Graf D, et al. Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur J Immunol 1994, 24:1919-1924.
45. Buckley RH Advances in the understanding and treatment of human severe combined immunodeficiency. Immunol Res 2000, 22:237-251.
46. Buckley RH, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997, 130:378-387.
47. Bussel JB, Cunningham-Rundles S, LaGamma EF, et al. Analysis of lymphocyte proliferative response subpopulations in very low birth weight infants and during the first 8 weeks of life. Pediatr Res 1988, 23:457-462.
48. Cairo MS Granulocyte transfusions in neonates with presumed sepsis. Pediatrics 1987, 80:738-740.
49. Cairo MS Cytokines: A new immunotherapy. Clin Perinatol 1991, 18:343-359.
50. Cairo MS, Rucker R, Bennetts GA, et al. Improved survival of newborns receiving leukocyte transfusions for sepsis. Pediatrics 1984, 74:887-892.
51. Cairo MS, Worcester C, Rucker R, et al. Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis. JPediatr 1987, 110:935-941.
52. Cairo MS, VandeVen C, Toy C, et al. GM-CSF primes and modulates neonatal PMN motility: Up-regulation of C3bi (Mo1) expression with alteration in PMN adherence and aggregation. Am J Pediatr Hematol Oncol 1991, 13:249-257.
53. Cairo MS, Worcester CC, Rucker RW, et al. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis [see comments]. JPediatr 1992, 120:281-285.
54. Calame KL Plasma cells: finding new light at the end of B cell development. Nature Immunol 2001, 2:1103-1108.
55. Cantrell DA T-cell antigen receptor signal transduction. Immunology 2002, 105:369-374.
56. Cao X, Shores EW, Hu-Li J, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223-238.
57. Cates KL, Goetz C, Rosenberg N, et al. Longitudinal development of specific and functional antibody in very low birth weight premature infants. Pediatr Res 1988, 23:14-22.
58. Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morbid Mortal Wkly Rep 2001, 50(RR-2):1-25. Centers for Disease Control and Prevention.
59. Cerwenka A, Lanier LL Natural killer cells, viruses and cancer. Nature Rev Immunol 2001, 1:41-49.
60. Chaouat G, Menu E, Clark DA, et al. Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990, 89:447-458.
61. Chatterjee-Hasrouni S, Lala PK Localization of paternal H-2K antigens on murine trophoblast cells in vivo. J Exp Med 1982, 155:1679-1689.
62. Christensen KK, Christensen P IgG subclasses and neonatal infections with group B streptococci. Monogr Allergy 1988, 23:138-147.
63. Christensen RD Hematopoiesis in the fetus and neonate. Pediatr Res 1989, 26:531-535.
64. Christensen RD, Shigeoka AO, Hill HR, et al. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis. Pediatr Res 1980, 14:806-808.
65. Christensen RD, Anstall HB, Rothstein G Use of whole blood exchange transfusion to supply neutrophils to septic, neutropenic neonates. Transfusion 1982, 22:504-506.
66. Christensen RD, Brown MS, Hall DC, et al. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis [see comments]. J Pediatr 1991, 118:606-614.
67. Clapp DW, Kliegman RM, Baley JE, et al. Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study [see comments]. J Pediatrics 1989, 115:973-978.
68. Clark DA, Quarrington C, Banwatt D, et al. Spontaneous abortion in immunodeficient SCID mice. Am J Reprod Immunol (Copenh) 1994, 32:15-25.
69. Clark SJ, Cabana MD, Malik T, et al. Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations. Arch Pediatr Adolesc Med 2001, 155:915-920.
70. Cole CH, Colton C, Shah BL, et al. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med 1999, 340:1005-1010.
71. Cole FS Complement function in the neonate. Immunology of the Neonate 1987, 76-82. Springer Verlag, Berlin. G.R. Burgio, L.A. Hanson, A.G. Ugazio (Eds.).
72. Cole FS, Colten HR Complement. Neonatal Infections, Nutritional and Immunologic Interactions 1984, 37-49. Grune & Stratton, New York. P.L. Ogra (Ed.).
73. Colten HR Ontogeny of the human complement system: In vitro biosynthesis of individual complement components by fetal tissues. J Clin Invest 1972, 51:725-730.
74. Colten HR, Gitlin JD Immunoproteins. Blood: Principles and Practice of Hematology 1995, 477-511. JB Lippincott, Philadelphia. R.I. Handin, S.E. Lux, T.P. Stossel (Eds.).
75. Colten HR, Gordon JM, Borsos T, et al. Synthesis of the first component of human complement in vitro. J Exp Med 1968, 128:595-604.
76. Colten HR, Alper CA, Rosen FS Genetics and biosynthesis of complement proteins. N Engl J Med 1981, 304:653-656.
77. Recommended childhood immunization schedule-United States, 2002. Pediatrics 2002, 109:162. Committee on Infectious Diseases, American Academy of Pediatrics, Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, American Academy of Family Physicians.
78. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002, 109:330-338. Committee on the Fetus and Newborn.
79. Conway S, James J, Balfour A, et al. Immunisation of the preterm baby. [see comments]. J Infection 1993, 27:143-150.
80. Cooper MA, Fehniger TA, Caligiuri MA The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
81. Corneo B, Moshous D, Callebaut I, et al. Three-dimensional clustering of human RAG2 gene mutations in severe combined immune deficiency. J Biol Chem 2000, 275:12672-12675.
82. Corneo B, Moshous D, Gungor T, et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood 2001, 97:2772-2776.
83. Correa AG, Baker CJ, Schutze GE, et al. Immunoglobulin G enhances C3 degradation on coagulase-negative staphylococci. Infect Immun 1994, 62:2362-2366.
84. Croy BA The application of SCID mouse technology to questions in reproductive biology. Lab Animal Sci 1993, 43:123-126.
85. Croy BA, Chapeau C Evaluation of the pregnancy immunotrophism hypothesis by assessment of the reproductive performance of young adult mice of genotype SCID/SCID.BG/BG. J Reprod Fertil 1990, 88:231-239.
86. Croy BA, Stewart CM, McBey BA, et al. An immunohistologic analysis of murine uterine T cells between birth and puberty. JReprod Immunol 1993, 23:223-233.
87. Cummings JJ, D'Eugenio DB, Gross SJ A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989, 320:1505-1510.
88. Dancis J, Osborn JJ, Kunz HW Studies of the immunology of the neonate infants. IV: Antibody formation in the premature infant. Pediatrics 1953, 12:151-157.
89. D'Angio CT Immunization of the premature infant. Pediatr Infect Dis J 1999, 18:824-825.
90. Davis CA, Vallota EH, Forristal J Serum complement levels in infancy: Age related changes. Pediatr Res 1979, 13:1043-1046.
91. Davis MM, Kim SK, Hood L Immunoglobulin class switching: Developmentally regulated DNA rearrangements during differentiation. Cell 1980, 22:1-2.
92. de Fougerolles AR, Baines MG Modulation of the natural killer cell activity in pregnant mice alters the spontaneous abortion rate. J Reprod Immunol 1987, 11:147-153.
93. Denison FC, Grant VE, Calder AA, et al. Seminal plasma components stimulate interleukin-8 and interleukin-10 release. Molec Hum Reprod 1999, 5:220-226.
94. Derry JM, Ochs HD, Francke U Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994, 78:635-644.
95. DiSanto JP, Muller W, Guy-Grand D, et al. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A 1995, 92:377-381.
96. Dominguez M, Yacoub M, Dominguez E Fetal natural killer cell function is suppressed. Immunology 1993, 79:119-124.
97. Duclos AJ, Pomerantz DK, Baines MG Relationship between decidual leukocyte infiltration and spontaneous abortion in a murine model of early fetal resorption. Cell Immunol 1994, 159:184-193.
98. Edwards MS Complement in neonatal infections: An overview. Pediatr Infect Dis 1986, 5:S168-S170.
99. Edwards MS, Buffone GJ, Fuselier PA, et al. Deficient classical complement pathway activity in newborn sera. Pediatr Res 1983, 17:685-688.
100. Ehring GR, Kerschbaum HH, Eder C, et al. A nongenomic mechanism for progesterone-mediated immunosuppression: Inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes. J Exp Med 1998, 188:1593-1602.
101. Eibl MM, Wolf HM, Furnkranz H, et al. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N Engl J Med 1988, 319:1-7.
102. Eklund J, Nevanlinna HR Perinatal mortality from Rh(D) hemolytic disease in Finland, 1975-1984. Acta Obstet Gynecol Scand 1986, 65:787-789.
103. English BK, Burchett SK, English JD, et al. Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells. Pediatr Res 1988, 24:717-722.
104. Enserink M Bioterrorism: How devastating would a smallpox attack really be?. Science 2002, 297:50-51.
105. Evans PC, Lambert N, Maloney S, et al. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033-2037.
106. Faix RG Immunization during pregnancy. Clin Obstet Gynecol 2002, 45:52-58.
107. Falk I, Nerz G, Haidl I, et al. Immature thymocytes that fail to express TCRbeta and/or TCRgamma delta proteins die by apoptotic cell death in the CD44(-)CD25(-) (DN4) subset. Eur J Immunol 2001, 31:3308-3317.
108. Fanaroff AA, Korones SB, Wright LL, et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network [see comments]. N Engl J Med 1994, 330:1107-1113.
109. Fernandez JA, Estelles A, Gilabert J, et al. Functional and immunologic protein S in normal pregnant women and in full-term newborns. Thromb Haemost 1989, 61:474-478.
110. Fietta A, Sacchi F, Bersani C, et al. Complement-dependent bactericidal activity for E. coli K12 in serum of preterm newborn infants. Acta Paediatr Scand 1987, 76:37-41.
111. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich Syndrome: Collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001, 97:1598-1603.
112. Fischer A Severe combined immunodeficiencies (SCID). Clin Exp Immunol 2000, 122:143-149.
113. Fischer A, Cavazzana-Calvo M, De Saint Basile G, et al. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol 1997, 15:93-124.
114. Fischer GW Immunoglobulin therapy of neonatal group B streptococcal infections: An overview. Pediatr Infect Dis 1988, J7:S13-S16.
115. Flake AW, Roncarolo MG, Puck JM, et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996, 335:1806-1810.
116. Frank MM Complement deficiencies. Pediatr Clin North Am 2000, 47:1339-1354.
117. Frenkel L, Bryson YJ Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: Evidence for decreased production in infants younger than 2 months of age. J Pediatr 1987, 111:97-100.
118. Fudenberg HH Gm genes and gamma globulin synthesis in the human fetus. J Immunol 1965, 94:514-520.
119. Fuleihan R, Ahern D, Geha RS Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur J Immunol 1994, 24:1925-1928.
120. Gans HA, Arvin AM, Galinus J, et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 1998, 280:527-532.
121. Garcia AM, Fadel SA, Cao S, et al. T cell immunity in neonates. Immunol Res 2001, 22:177-190.
122. Gathings WE, Lawton AR, Cooper MD Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol 1977, 7:804-810.
123. Gatti RA, Meuwissen HJ, Allen HD, et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968, 2(7583):1366-1369.
124. Gendron RL, Nestel FP, Lapp WS, et al. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumour necrosis factor-alpha. J Reprod Fertil 1990, 90:395-402.
125. Gennery AR, Cant AJ Diagnosis of severe combined immunodeficiency. J Clin Pathol 2001, 54:191-195.
126. Georgeson GD, Szony BJ, Streitman K, et al. Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections. Eur J Pediatr 2001, 160:478-482.
127. Georgopoulos K Haematopoietic cell-fate decisions, chromatin regulation and Ikaros. Nature Rev Immunol 2002, 2:162-174.
128. Gill TJ Reproductive immunology: A personal view. Am J Reprod Immunol (Copenh) 1992, 27:87-88.
129. Gill TJ, Repetti CF, Metlay LA, et al. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 1983, 72:987-996.
130. Gill TJ, Karasic RB, Antoncic J, et al. Long-term follow-up of children born to women immunized with tetanus toxoid during pregnancy. Am J Reprod Immunol (Copenh) 1991, 25:69-71.
131. Gillan ER, Christensen RD, Suen Y, et al. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophilia. Blood 1994, 84:1427-1433.
132. Gitlin D, Kumate J, Urrusti J The selectivity of the human placenta in the transfer of plasma proteins from mother to fetus. JClin Invest 1964, 43:1938-1951.
133. Gitlin D, Biasucci A Development of gamma G, gamma A, gamma M, beta IC-beta IA, C1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin in the human conceptus. J Clin Invest 1969, 48:1433-1446.
134. Gong Q, Cheng AM, Akk AM, et al. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nature Immunol 2001, 2:29-36.
135. Gong S, Nussenzweig MC Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science 1996, 272:411-414.
136. Greenberg DP Pediatr experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr Infect Dis J 1993, 12:438-445.
137. Groneck P, Oppermann M, Speer CP Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment. Pediatr Res 1993, 34:586-590.
138. Groneck P, Gotze-Speer B, Oppermann M, et al. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates [see comments]. Pediatrics 1994, 93:712-718.
139. Guest SS, Smale ST, Hahm K, et al. Lack of natural killer cell precursors in fetal liver of Ikaros knockout mutant mice. Cell 1997, 91:845-854.
140. Guilbert L, Robertson SA, Wegmann TG The trophoblast as an integral component of a macrophage-cytokine network. Immunol Cell Biol 1993, 71:49-57.
141. Gurka G, Rocklin RE Reproductive immunology. JAMA 1987, 258:2983-2987.
142. Hackley BK Immunizations in pregnancy: A public health perspective. J Nurse-Midwifery 1999, 44:106-117.
143. Haddad EK, Duclos AJ, Baines MG Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med 1995, 182:1143-1151.
144. Haddad EK, Duclos AJ, Lapp WS, et al. Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua. J Immunol 1997, 158:4886-4892.
145. Haimovici F, Hill JA, Anderson DJ The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol Reprod 1991, 44:69-75.
146. Hall JG Catch 22. J Med Genet 1993, 30:801-802.
147. Haque KN, Zaidi MH, Bahakim H IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child 1988, 142:1293-1296.
148. Hardy RR, Hayakawa K B cell development pathways. Annu Rev Immunol 2001, 19:595-621.
149. Harland C, Shah T, Webster AD, et al. Dipeptidyl peptidase IV: Subcellular localization, activity and kinetics in lymphocytes from control subjects, immunodeficient patients and cord blood. Clinical Exp Immunol 1988, 74:201-205.
150. Hartley SB, Crosbie J, Brink R, et al. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991, 353:765-769.
151. Hauser GJ, Zakuth V, Rosenberg H, et al. Interleukin-2 production by cord blood lymphocytes stimulated with mitogen and in the mixed leukocyte culture. J Clin Lab Immunol 1985, 16:37-40.
152. Hayward AR, Mori M Human newborn autologous mixed lymphocyte response: Frequency and phenotype of responders and xenoantigen specificity. J Immunol 1984, 133:719-723.
153. Hemming VG, Hall RT, Rhodes PG, et al. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J Clin Invest 1976, 58:1379-1387.
154. Hepatitis B vaccination-United States, 1982-2002. MMWR Morbid Mortal Wkly Rep 2002, 51:549-563.
155. A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morbid Mortal Wkly Rep 1991, 40:1-25. Hepatitis B virus.
156. Hicks MJ, Jones JF, Thies AC, et al. Age-related changes in mitogen-induced lymphocyte function from birth to old age. Am J Clin Pathol 1983, 80:159-163.
157. Hill HR Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 1987, 22:375-382.
158. Hill HR Intravenous immunoglobulin use in the neonate: Role in prophylaxis and therapy of infection. Pediatr Infect Dis Journal 1993, 12:549-558.
159. Hill HR Modulation of host defenses with interferon-gamma in pediatrics. J Infect Dis 1993, 167(Suppl 1):S23-S28.
160. Hill HR, Shigeoka AO, Pincus S, et al. Intravenous IgG in combination with other modalities in the treatment of neonatal infection. Pediatr Infect Dis 1986, 5:S180-S184.
161. Hill HR, Augustine NH, Jaffe HS Human recombinant interferon gamma enhances neonatal polymorphonuclear leukocyte activation and movement, and increases free intracellular calcium. J Exp Med 1991, 173:767-770.
162. Hirschhorn R Adenosine deaminase deficiency. Immunodefic Rev 1990, 2:175-198.
163. Hogg N, Harvey J, Cabanas C, et al. Control of leukocyte integrin activation. Am Rev Respir Dis 1993, 148:S55-S59.
164. Holzgreve B, Goldsmith PC, Holzgreve W, et al. A monoclonal antibody micromethod for studying fetal lymphocytes: Potential for prenatal diagnosis of inherited immunodeficiencies. JReproductive Immunol 1984, 6:341-344.
165. Hunt JS, Vassmer D, Ferguson TA, et al. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. JImmunol 1997, 158:4122-4128.
166. Hunziker RD, Wegmann TG Placental immunoregulation. Crit Rev Immunol 1986, 6:245-285.
167. Ingelsby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: Updated recommendations for management. JAMA 2002, 287:2236-2252.
168. Insel RA, Amstey M, Woodin K, et al. Maternal immunization to prevent infectious diseases in the neonate or infant. Int J Technol Assess Health Care 1994, 10:143-153.
169. New vaccine development: Establishing priorities. Diseases of importance in the United States 1985, Institute of Medical and National Academy of Sciences, National Academy Press, Washington, DC.
170. Jacoby DR, Oldstone MB Delineation of suppressor and helper activity within the OKT4-defined T lymphocyte subset in human newborns. J Immunol 1983, 131:1765-1770.
171. Jacoby DR, Olding LB, Oldstone MB Immunologic regulation of fetal-maternal balance. Adv Immunol 1984, 35:157-208.
172. Jarrett EE Perinatal influences on IgE responses. Lancet 1984, 2:797-799.
173. Jiang SP, Vacchio MS Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft". J Immunol 1998, 160:3086-3090.
174. Johnson RJ Complement activation during extracorporeal therapy: Biochemistry, cell biology and clinical relevance. Nephrol Dial Transplant 1994, 9(Suppl 2):36-45.
175. Kadowaki N, Antonenko S, Ho S, et al. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 2001, 193:1221-1226.
176. Kalli KR, Hsu P Fearon DT Therapeutic uses of recombinant complement protein inhibitors. Springer Semin Immunopathol 1994, 15:417-431.
177. Kannourakis G, Begley CG, Johnson GR, et al. Evidence for interactions between monocytes and natural killer cells in the regulation of in vitro hemopoiesis. J Immunol 1988, 140:2489-2494.
178. Kao JH, Chen DS Global control of hepatitis B virus infection. Lancet Infect Dis 2002, 2:395-403.
179. Kennedy B, Evans PA, Davies FE, et al. The human thymus during aging. Blood 2001, 98:29-35.
180. Kincade PW, Medina KL, Payne KJ, et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000, 175:128-137.
181. King A, Boocock C, Sharkey AM, et al. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 1996, 156:2068-2076.
182. King A, Burrows T, Loke YW Human uterine natural killer cells. Nat Immun 1996, 15:41-52.
183. Kinney J, Mundorf L, Gleason C, et al. Efficacy and pharmacokinetics of intravenous immune globulin administration to high-risk neonates. Am J Dis Child 1991, 145:1233-1238.
184. Kinsky R, Delage G, Rosin N, et al. A murine model of NK cell mediated resorption. Am J Reprod Immunol (Copenh) 1990, 23:73-77.
185. Kitamura D, Kudo A, Schaal S, et al. A critical role of lambda 5 protein in B cell development. Cell 1992, 69:823-831.
186. Klein GL, Neibart SI, Hassman H, et al. Little evidence of HLA-G mRNA polymorphism in Caucasian or Afro-Caribbean populations. Clin Pediatr 1998, 37:17-22.
187. Klesius PH, Zimmerman RA, Mathews JH, et al. Cellular and humoral immune response to group B streptococci. J Pediatr 1973, 83:926-932.
188. Kohn DB Gene therapy for genetic haematological disorders and immunodeficiencies. J Intern Med 2001, 249:379-390.
189. Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
190. Krause PJ, Herson VC, Eisenfeld L, et al. Enhancement of neutrophil function for treatment of neonatal infections. Pediatr Infect Dis J 1989, 8:382-389.
191. Krensky AM, Clayberger C Transplantation immunology. Pediatr Clin North Am 1994, 41:819-839.
192. Lanier LL NK cell receptors. Annu Rev Immunol 1998, 16:359-393.
193. Lanier LL, Corliss B, Wu J, et al. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998, 8:693-701.
194. Lassiter HA, Watson SW, Seifring ML, et al. Complement factor 9 deficiency in serum of human neonates. J Infect Dis 1992, 166:53-57.
195. Lassiter HA, Wilson JL, Feldhoff RC, et al. Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coli. Pediatr Res 1994, 35:389-396.
196. Lassoued K, Illges H, Benlagha K, Cooper MD Fate of surrogate light chains in B lineage cells. J Exp Med 1996, 183:421.
197. Lawrence G, Tudehope D, Baumann K, et al. Enteral human IgG for prevention of necrotizing enterocolitis: A placebo-controlled, randomised trial. Lancet 2001, 357:2090-2094.
198. Lawton AR Immunization of the neonate. Int J Technol Assess Health Care 1994, 10:154-160.
199. Lee N, Malacko AR, Ishitani A, et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995, 3:591-600.
200. Leung DY Mechanisms of the human allergic response: Clinical implications. Pediatr Clin North Am 1994, 41:727-743.
201. Li YS, Hayakawa K, Hardy RR The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med 1993, 178:951-960.
202. Liang DC, Ma SW, Lin-Chu M, et al. Granulocyte/macrophage colony-forming units from cord blood of premature and full-term neonates: Its role in ontogeny of human hemopoiesis. Pediatr Res 1988, 24:701-702.
203. Lilja G, Winbladh B, Vedin I, et al. Cord blood T lymphocyte subpopulations in premature and full-term infants. Int Arch Allergy Appl Immunol 1984, 75:273-275.
204. Linder N, Ohel G In utero vaccination. Clin Perinatol 1994, 21:663-674.
205. Llano M, Bellon T, Colonna M, et al. How do NK cells sense the expression of HLA-G class Ib molecules?. Eur J Immunol 1999, 29:277-283.
206. Lo YM, Lo ES, Watson N, et al. Two-way cell traffic between mother and fetus: Biologic and clinical implications. Blood 1996, 88:4390-4395.
207. Lohoff M, Duncan GS, Ferrick D, et al. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med 2000, 192:325-336.
208. Lu CY, Calamai EG, Unanue ER A defect in the antigen-presenting function of macrophages from neonatal milk. Nature 1979, 282:327-329.
209. Macchi P, Villa A, Giliani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995, 377:65-68.
210. Madoff LC, Paoletti LC, Tai JY, et al. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J Clin Invest 1994, 94:286-292.
211. Magny JF, Bremard-Oury C, Brault D, et al. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature infants: report of a multicenter, double-blind study [see comments]. Pediatrics 1991, 88:437-443.
212. Malm J, Bennhagen R, Holmberg L, et al. Plasma concentrations of C4b-binding protein and vitamin K-dependent protein S in term and preterm infants: Low levels of protein S-C4b-binding protein complexes. Br J Haematol 1988, 68:445-449.
213. Markert ML, Hummell DS, Rosenblatt HM, et al. Complete DiGeorge syndrome: Persistence of profound immunodeficiency. J Pediatr 1998, 132:15-21.
214. Massey GV, McWilliams NB, Mueller DG, et al. Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopenia. J Pediatr 1987, 111:133-135.
215. McMaster MT, Librach CL, Zhou Y, et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995, 154:3771-3778.
216. Medawar PB Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953, 7:320.
217. Melchers F, Rolink A B-lymphocyte development and biology. Fundamental Immunology 1999, 183-224. Lippincott-Raven, Philadelphia. 4th ed. W.E. Paul (Ed.).
218. Melissari E, Nicolaides KH, Scully MF, et al. Protein S and C4b-binding protein in fetal and neonatal blood. Br J Haematol 1988, 70:199-203.
219. Mellor AL, Munn DH Immunology at the maternal-fetal interface: Lessons for T cell tolerance and suppression. Annu Rev Immunol 2000, 18:367-391.
220. Menitove JE, Abrams RA Granulocyte transfusions in neutropenic patients. Crit Rev Oncol Hematol 1987, 7:89-113.
221. Merscher S, Funke B, Epstein JA, et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104:619-629.
222. Mills L, Napier JA Massive feto-maternal haemorrhage: Effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn. Br J Obstet Gynaecol 1988, 95:1007-1012.
223. Miyano A, Nakayama M, Fujita T, et al. Complement activation in fetuses: Assessment by the levels of complement components and split products in cord blood. Diagn Clin Immunol 1987, 5:86-90.
224. Miyaura H, Iwata M Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002, 168:1087-1094.
225. Moalic P, Gruel Y, Body G, et al. Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns. Thromb Res 1988, 49:471-480.
226. Morell A, Sidiropoulos D, Herrmann U, et al. IgG subclasses and antibodies to group B streptococci in preterm neonates after intravenous infusion of immunoglobulin to the mothers. Pediatr Infect Dis 1986, 5:S195-S197.
227. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Ann Rev Immunol 2001, 19:197-223.
228. Morris AC, Riley JL, Fleming WH, et al. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression. Am J Reprod Immunol 1998, 40:385-394.
229. Mrozek E, Anderson P, Caligiuri MA Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996, 87:2632-2640.
230. Muller-Eberhard HJ The membrane attack complex of complement. Annu Rev Immunol 1986, 4:503-528.
231. Munn DH, Shafizadeh E, Attwood JT, et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999, 189:1363-1372.
232. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998, 281:1191-1193.
233. Murphy SP, Tomasi TB Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression. Mol Reprod Dev 1998, 51:1-12.
234. Nelson DL, Kurman CC, Fritz ME, et al. The production of soluble and cellular interleukin-2 receptors by cord blood mononuclear cells following in vitro activation. Pediatr Res 1986, 20:136-139.
235. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73:147-157.
236. Norwitz ER, Schust DJ, Fisher SJ Implantation and the survival of early pregnancy. N Engl J Med 2001, 345:1400-1408.
237. Noya FJ, Baker CJ Intravenously administered immune globulin for premature infants: A time to wait [letter; comment]. JPediatr 1989, 115:969-971.
238. Noya FJ, Baker CJ Prevention of group B streptococcal infection. Infect Dis Clin North Am 1992, 6:41-55.
239. Ogasawara N, Moszer I, Albertini AM, et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells [erratum appears in Nature 1998 Apr 392:843, 1998]. Nature 1998, 390:249-256.
240. Olding LB, Oldstone MB Lymphocytes from human newborns abrogate mitosis of their mother's lymphocytes. Nature 1974, 249:161-162.
241. Oldstone MB, Tishon A, Moretta L Active thymus derived suppressor lymphocytes in human cord blood. Nature 1977, 269:333-335.
242. Ossa JE, Cadavid AP, Maldonado JG Is the immune system necessary for placental reproduction? A hypothesis on the mechanisms of alloimmunotherapy in recurrent spontaneous abortion. Med Hypotheses 1994, 42:193-197.
243. Ouyang W, Lohning M, Assenmacher M, et al. T helper subset development: Roles of instruction, selection, and transcription. J Exp Med 2001, 193:643-650.
244. Owen JJ, Wright DE, Habu S, et al. Studies on the generation of B lymphocytes in fetal liver and bone marrow. J Immunol 1977, 118:2067-2072.
245. Pangburn MK, Muller-Eberhard HJ The alternative pathway of complement. Springer Semin Immunopathol 1984, 7:163-192.
246. Papadogiannakis N, Johnsen SA Distinct mitogens reveal different mechanisms of suppressor activity in human cord blood. JClin Lab Immunol 1988, 26:37-41.
247. Pedersen SA, Petersen J, Andersen V Suppression of B lymphocytes in mature newborn infants. Acta Paediatr Scand 1983, 72:441-447.
248. Penix L, Weaver WM, Pang Y, et al. Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J Exp Med 1993, 178:1483-1496.
249. Pereira S, Webster D, Platts-Mills T Immature B cells in fetal development and immunodeficiency: Studies of IgM, IgG, IgA and IgD production in vitro using Epstein-Barr virus activation. Eur J Immunol 1982, 12:540-546.
250. Perignon JL, Durandy A, Peter MO, et al. Early prenatal diagnosis of inherited severe immunodeficiencies linked to enzyme deficiencies. J Pediatr 1987, 111:595-598.
251. Peschon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyteexpansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
252. Peter G Summary of major changes in the 1994 Red Book: American Academy of Pediatrics Report of the Committee on Infectious Disease. Pediatrics 1994, 93:1000-1002.
253. Philpott KL, Rastan S, Brown S, et al. Expression of H-2 class I genes in murine extra-embryonic tissues. Immunology 1988, 64:479-485.
254. Piccinni MP, Giudizi MG, Biagiotti R, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995, 155:128-133.
255. Piccinni MP, Beloni L, Livi C, et al. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nature Med 1998, 4:1020-1024.
256. Pittard WB, Miller K, Sorensen RU Normal lymphocyte responses to mitogens in term and premature neonates following normal and abnormal intrauterine growth. Clin Immunol Immunopathol 1984, 30:178-187.
257. Pittard WB, Miller KM, Sorensen RU Perinatal influences on in vitro B lymphocyte differentiation in human neonates. Pediatr Res 1985, 19:655-658.
258. Pittard WB, Schleich DM, Geddes KM, et al. Newborn lymphocyte subpopulations: The influence of labor. Am J Obstet Gynecol 1989, 160:151-154.
259. Polgar K, Anderson DJ Immune interferon gamma inhibits translational mobility of a plasma membrane protein in preimplantation stage mouse embryos: A T-helper 1 mechanism for immunologic reproductive failure. JAMA 1995, 273:1933-1936.
260. Polin RA, Harris MC Neonatal bacterial meningitis. Semin Perinatol 2001, 6:157-172.
261. Pollack MS, Kirkpatrick D, Kapoor N, et al. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl JMed 1982, 307:662-666.
262. Ponte M, Cantoni C, Biassoni R, et al. Inhibitory receptors sensing HLA-G molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A 1999, 96:5674-5679.
263. Propp RP, Alper CA C'3 synthesis in the human fetus and lack of transplacental passage. Science 1968, 162:672-673.
264. Puck JM, Middelton L, Pepper AE Carrier and prenatal diagnosis of X-linked severe combined immunodeficiency: Mutation detection methods and utilization. Human Genetics 1997, 99:628-633.
265. Puel A, Ziegler SF, Buckley RH, et al. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nature Genet 1998, 20:394-397.
266. Rajagopalan S, Long EO A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells [erratum appears in J Exp Med 191:2027, 2000]. JExp Med 1999, 189:1093-1100.
267. Raum DD, Awdeh ZL, Page PL, et al. MHC determinants of response to Rh immunization. J Immunol 1984, 132:157-159.
268. Ravetch JV, Lanier LL Immune inhibitory receptors. Science 2000, 290:84-89.
269. Recommended childhood immunization schedule-United States, 2002. MMWR Morbid Mortal Wkly Rep 2002, 51:31-33.
270. Reinherz EL, Cooper MD, Schlossman SF, et al. Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders. J Clin Invest 1981, 68:699-705.
271. Rengan R, Ochs HD Molecular biology of the Wiskott-Aldrich syndrome. Rev Immunogenet 2000, 2:243-255.
272. Res P, Martinez-Caceres E, Cristina Jaleco A, et al. CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood 1996, 87:5196-5206.
273. Ricevuti G, Mazzone A Clinical aspects of neutrophil locomotion disorders. Biomed Pharmacother 1987, 41:355-367.
274. Robertson SA, Roberts CT, Farr KL, et al. Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice. Biol Reprod 1999, 60:251-261.
275. Roder J, Duwe A The beige mutation in the mouse selectively impairs natural killer cell function. Nature 1979, 278:451-453.
276. Rogers MH, Lwin R, Fairbanks L, et al. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency. J Pediatr 2001, 139:44-50.
277. Rohrer J, Minegishi Y, Conley ME Defects in early B-cell development: Comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Clin Rev Allergy Immunol 2000, 19:183-204.
278. Rolink AG, Schaniel C, Andersson J, et al. Selection events operating at various stages in B cell development. Curr Opin Immunol 2001, 13:202-207.
279. Romero R, Sepulveda W, Kenney JS, et al. Interleukin 6 determination in the detection of microbial invasion of the amniotic cavity. Ciba Found Symp 1992, 167:205-220. discussion 220-223.
280. Romero R, Mazor M, Munoz H, et al. The preterm labor syndrome. Ann N Y Acad Sci 1994, 734:414-429.
281. Rosen FS Defects in cell-mediated immunity. Clin Immunol Immunopathol 1986, 41:1-7.
282. Rosen FS, Janeway CA Immunologic competence of the newborn infant. Pediatrics 1964, 33:159-160.
283. Rosen FS, Cooper MD, Wedgwood RJ The primary immunodeficiencies (2). N Engl J Med 1984, 311:300-310.
284. Rouas-Freiss N, Goncalves RM, Menier C, et al. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997, 94:11520-11525.
285. Rubaltelli FF, Benini F, Sala M Prevention of necrotizing enterocolitis in neonates at risk by oral administration of monomeric IgG. Dev Pharmacol Ther 1991, 17:138-143.
286. Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development. Science 1995, 270:797-800.
287. Ryhanen P, Jouppila R, Lanning M, et al. Effect of segmental epidural analgesia on changes in peripheral blood leucocyte counts, lymphocyte subpopulations, and in vitro transformation in healthy parturients and their newborns. Gynecol Obstet Invest 1984, 17:202-207.
288. Santisteban I, Arredondo-Vega FX, Kelly S, et al. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease: Contribution of genotype to phenotype. J Clin Invest 1993, 92:2291-2302.
289. Santos JI, Shigeoka AO, Hill HR Functional leukocyte administration in protection against experimental neonatal infection. Pediatr Res 1980, 14:1408-1410.
290. Sargent IL Maternal and fetal immune responses during pregnancy. Exp Clin Immunogenet 1993, 10:85-102.
291. Scambler PJ The 22q11 deletion syndromes. Hum Molec Genet 2000, 9:2421-2426.
292. Schieren G, Hansch GM Membrane-associated proteins regulating the complement system: Functions and deficiencies. Int Rev Immunol 1993, 10:87-101.
293. Schofield F Selective primary health care: Strategies for control of disease in the developing world. XXII: Tetanus: A preventable problem. Rev Infect Dis 1986, 8:144-156.
294. Schwarz K, Gauss GH, Ludwig L, et al. RAG mutations in human B cell-negative SCID. Science 1996, 274:97-99.
295. Shah SS, Ehrenkranz RA, Gallagher PG Increasing incidence of gram-negative rod bacteremia in a newborn intensive care unit. Pediatr Infect Dis J 1999, 18:591-595.
296. Shapiro R, Beatty DW, Woods DL, et al. Complement activity in the cord blood of term neonates with the amniotic fluid infection syndrome. S Afr Med J 1983, 63:86-87.
297. Sidiropoulos D, Boehme U, Von Muralt G, et al. Immunoglobulin supplementation in prevention or treatment of neonatal sepsis. Pediatr Infect Dis 1986, 5:S193-S194.
298. Siegrist CA Neonatal and early life vacinology. Vaccine 2001, 19:3331-3346.
299. Simmons RL Histoincompatibility and the survival of the fetus: Current controversies. Transplant Proc 1969, 1:47-52.
300. Simmons RL, Russell PS Immunologic interactions between the mother and fetus. Adv Obstet Gynecol 1967, 1:38.
301. Simpson KL, Houlihan JM, Holmes CH Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver. Immunology 1993, 80:183-190.
302. Soderstrom K, Corliss B, Lanier LL, et al. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 1997, 159:1072-1075.
303. Sonntag J, Brandenburg U, Pulzehl D, et al. Complement system in healthy term newborns: Reference values in umbilical cord blood. Pediatr Dev Pathol 1998, 1:131-135.
304. Sorensen RU, Polmar SH Immunoglobulin replacement therapy. Ann Clin Res 1987, 19:293-304.
305. Spits H, Blom B, Jaleco AC, et al. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev 1998, 165:75-86.
306. Sprent J T cell memory. Microbes Infect 2002, 4:51-56.
307. Stegagno M, Pascone R, Colarizi P, et al. Immunologic follow-up of infants treated with granulocyte transfusion for neonatal sepsis. Pediatrics 1985, 76:508-511.
308. Stephan JL, Vlekova V, Le Deist F, et al. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993, 123:564-572.
309. Stevenson AM Immunizations for women and infants. J Obstet Gynecol Neonatal Nurs 1999, 28:534-544.
310. Stewart CL Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992, 359:76-79.
311. Stiehm ER, Ammann AJ, Cherry JD Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med 1966, 275:971-977.
312. Stiehm ER, Sztein MB, Steeg PS, et al. Deficient DR antigen expression on human cord blood monocytes: Reversal with lymphokines. Clin Immunol Immunopathol 1984, 30:430-436.
313. Stiehm ER, Ashida E, Kim KS, et al. Intravenous immunoglobulins as therapeutic agents [erratum appears in Ann Intern Med 107:946, 1987]. Ann Intern Med 1987, 107:367-382.
314. Stossel TP, Alper CA, Rosen FS Opsonic activity in the newborn: Role of properdin. Pediatrics 1973, 52:134-137.
315. Strunk RC, Fenton LJ, Gaines JA Alternative pathway of complement activation in full term and premature infants. Pediatr Res 1979, 13:641-643.
316. Strunk RC, Fleischer JA, Katz Y, et al. Developmentally regulated effects of lipopolysaccharide on biosynthesis of the third component of complement and factor B in human fibroblasts and monocytes. Immunology 1994, 82:314-320.
317. Suarez VR, Hankins GD Smallpox and pregnancy: From eradicated disease to bioterrorist threat. Obstet Gynecol 2002, 100:87-93.
318. Sutton MB, Strunk RC, Cole FS Regulation of the synthesis of the third component of complement and factor B in cord blood monocytes by lipopolysaccharide. J Immunol 1986, 136:1366-1372.
319. Swinburne LM Leucocyte antigens and placental sponge. Lancet 1970, 2:592-594.
320. Symons M, Derry JM, Karlak B, et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 1996, 84:723-734.
321. Tafuri A, Alferink J, Moller P, et al. T cell awareness of paternal alloantigens during pregnancy. Science 1995, 270:630-633.
322. Tangri S, Wegmann TG, Lin H, et al. Maternal anti-placental reactivity in natural, immunologically-mediated fetal resorptions. J Immunol 1994, 152:4903-4911.
323. Tedder TF, Clement LT, Cooper MD Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody. J Immunol 1985, 134:1539-1544.
324. Tedder TF, Clement LT, Cooper MD Human lymphocyte differentiation antigens HB-10 and HB-11. I: Ontogeny of antigen expression. J Immunol 1985, 134:2983-2988.
325. Thompson LF, O'Connor RD, Bastian JF Phenotype and function of engrafted maternal T cells in patients with severe combined immunodeficiency. J Immunol 1984, 133:2513-2517.
326. Timens W, Rozeboom T, Poppema S Fetal and neonatal development of human spleen: An immunohistological study. Immunology 1987, 60:603-609.
327. Tongio MM, Mayer S, Lebec A Transfer of HL-A antibodies from the mother to the child. Complement of information. Transplantation 1975, 20:163-166.
328. Tremellen KP, Seamark RF, Robertson SA Seminal transforming growth factor beta-1 stimulates granulocyte-macrophage colony-stimulating factor production and inflammatory cell recruitment in the murine uterus. Biol Reprod 1998, 58:1217-1225.
329. van Tol MJ, Zijlstra J, Thomas CM, et al. Distinct role of neonatal and adult monocytes in the regulation of the in vitro antigen-induced plaque-forming cell response in man. J Immunol 1984, 133:1902-1908.
330. Vercellotti G, Stroncek D, Jacob HS Granulocyte oxygen radicals as potential suppressors of hemopoiesis: Potentiating roles of lactoferrin and elastase; inhibitory role of oxygen radical scavengers. Blood Cells 1987, 13:199-206.
331. Volanakis JE C3 convertases of complement. Year Immunol 1989, 4:218-230.
332. von Boehmer H, Fehling HJ Structure and function of the pre-T cell receptor. Annu Rev Immunol 1997, 15:433-452.
333. Wakasugi N, Virelizier JL Defective IFN-gamma production in the human neonate. I: Dysregulation rather than intrinsic abnormality. J Immunol 1985, 134:167-171.
334. Walsh JA, Hutchins S Group B streptococcal disease: Its importance in the developing world and prospect for prevention with vaccines [see comments]. Pediatr Infect Dis J 1989, 8:271-277.
335. Wegmann TG, Barrington LJ, Carlson GA Quantitation of the capacity of the mouse placenta to absorb monoclonal anti-fetal H-2k antibody. J Reprod Immunol 1980, 2:53.
336. Wegmann TG, Gill TJ, Nesbet-Brown E Molecular and Cellular Immunobiology of the Maternal Fetal Interface 1991, Oxford University Press, New York.
337. Weisman LE, Anthony BF, Hemming VG, et al. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. JPediatr 1993, 122:929-937.
338. Weisman LE, Cruess DF, Fischer GW Standard versus hyperimmune intravenous immunoglobulin in preventing or treating neonatal bacterial infections. Clin Perinatol 1993, 20:211-224.
339. Weisman LE, Stoll BJ, Kueser TJ, et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr 1994, 125:922-930.
340. Wessels MR, Paoletti LC, Rodewald AK, et al. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1993, 61:4760-4766.
341. Whitley RJ Neonatal herpes simplex virus infections: Is there a role for immunoglobulin in disease prevention and therapy?. Pediatr Infect Dis J 1994, 13:432-439.
342. Wiesen AR, Littell CT Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among U.S. Army women. JAMA 2002, 287:1556-1560.
343. Williams O, Brady HJ The role of molecules that mediate apoptosis in T-cell selection. Trends Immunol 2001, 22:107-111.
344. Wilson CB, Westall J, Johnston L, et al. Decreased production of interferon-gamma by human neonatal cells: Intrinsic and regulatory deficiencies. J Clin Invest 1986, 77:860-867.
345. Wilson CB, Penix L, Melvin A, et al. Lymphokine regulation and the role of abnormal regulation in immunodeficiency. Clin Immunol Immunopathol 1993, 67:S25-S32.
346. Wilson M, Rosen FS, Schlossman SF, et al. Ontogeny of human Tand B lymphocytes during stressed and normal gestation: Phenotypic analysis of umbilical cord lymphocytes from term and preterm infants. Clin Immunol Immunopathol 1985, 37:1-12.
347. Winter HS, Gard SE, Fischer TJ, et al. Deficient lymphokine production of newborn lymphocytes. Pediatr Res 1983, 17:573-578.
348. Wood CR, Chernova T, Chaudhary D, et al. The B7-CD28 superfamily. Nature Immunol 2001, 2:261-268.
349. Yamada H, Polgar K, Hill JA Cell-mediated immunity to trophoblast antigens in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1994, 170:1339-1344.
350. Yamashita Y, Thompson LF, Resta R Insights into adenosine deaminase deficiency provided by murine fetal thymic organ culture with 2'-deoxycoformycin. Immunol Rev 1998, 161:95-109.
351. Yankee TM, Clark EA Signaling through the B cell antigen receptor in developing B cells. Rev Immunogenet 2000, 2:185-203.
352. Young HA, Ghosh P, Ye J, et al. Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene. J Immunol 1994, 153:3603-3610.
353. Yun TJ, Bevan MJ The Goldilocks conditions applied to T cell development [letter; comment]. Nature Immunol 2001, 2:13-14.